Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Travel Awards - Institute Community Support

University of British Columbia

$1,500.00

Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers

FY 2023-24

Summary
Many chemotherapies and cancer treatment strategies aim to introduce DNA damage, ideally within the cancer cells and not normal, healthy cells. There are many pathways that cells can leverage to overcome this kind of damage, one of which is known as translesion synthesis. This pathway allows DNA replication to continue through the bulky lesions introduced by chemotherapy and radiation therapy. Therefore, it could be a viable strategy to target this pathway in cancer cells that are particularly reliant on it for the characteristic rapid growth seen most cancers. My project aims to uncover which particular cancer types and backgrounds may be the most susceptible to targeting of this DNA repair pathway as a treatment option.
Program
Travel Awards - Institute Community Support
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
495243
Name
White Justin M
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Travel Awards - Institute Community Support
Projecttitle
Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers
Programtype2
Undefined
Orgnameinp2
University of British Columbia
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Cancer Therapy; Chemoresistance; Dna Repair; Ics Travel Awards; Synthetic Lethality
Abstract
Many chemotherapies and cancer treatment strategies aim to introduce DNA damage, ideally within the cancer cells and not normal, healthy cells. There are many pathways that cells can leverage to overcome this kind of damage, one of which is known as translesion synthesis. This pathway allows DNA replication to continue through the bulky lesions introduced by chemotherapy and radiation therapy. Therefore, it could be a viable strategy to target this pathway in cancer cells that are particularly reliant on it for the characteristic rapid growth seen most cancers. My project aims to uncover which particular cancer types and backgrounds may be the most susceptible to targeting of this DNA repair pathway as a treatment option.
Competitiondate
202310
Approvedterm2
1 yr 0 mth
Pinamesdelim
White, Justin M
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $1,500~ $0~